Table 1. Baseline characteristics of study subjects.
Total Sample (N=20) |
Completed (N=15) |
Did Not Complete (N=5) |
P* | |
---|---|---|---|---|
Age | 59.0 ± 2.0 | 58.0 ± 2.5 | 62.0 ± 2.8 | 0.41 |
Height (cm) | 169.1 ± 2.2 | 171.1 ± 2.5 | 163.3 ± 4.3 | 0.13 |
Weight (kg) | 104.1 ± 3.6 | 106.2 ± 4.4 | 97.9 ± 5.4 | 0.33 |
BMI | 37.0 ± 1.4 | 36.9 ± 1.7 | 37.1 ± 2.6 | 0.96 |
Waist Circumference (cm)1 | 114.8 ± 2.3 | 117.0 ± 2.7 | 109.2 ± 3.8 | 0.14 |
Glucose (mg/dL) | 89.9 ± 3.5 | 91.3 ± 4.4 | 85.4 ± 4.0 | 0.47 |
TC (mg/dL) | 207.0 ± 11.8 | 208.5 ± 12.8 | 202.4 ± 30.1 | 0.83 |
LDL (mg/dL) | 122.3 ± 10.7 | 124.6 ± 10.9 | 115.4 ± 29.8 | 0.72 |
Triglycerides (mg/dL) | 199.2 ± 22.5 | 218.3 ± 26.1 | 142.0 ± 36.3 | 0.15 |
HDL (mg/dL) | 45.7 ± 3.6 | 41.3 ± 3.1 | 58.6 ± 9.1 | 0.03 |
Systolic BP (mmHg) | 138.4 ± 3.0 | 138.9 ± 3.8 | 136.8 ± 4.7 | 0.78 |
Diastolic BP(mmHg) | 80.6 ± 2.0 | 81.5 ± 2.3 | 77.8 ± 4.2 | 0.43 |
Exercise (hrs/week) | 4.1 ± 1.4 | 2.9 ± 1.1 | 7.8 ± 4.6 | 0.13 |
N (%) | N(%) | N(%) | ||
Male | 10 (50%) | 9 (60%) | 1 (20%) | 0.30 |
Caucasian | 15 (75%) | 13 (87%) | 2 (40%) | 0.07 |
African American2 | 4 (21%) | 2 (13%) | 2 (50%) | 0.18 |
Blood Pressure Medications3 | 4 (22%) | 4 (27%) | 0 (0%) | 1 |
Cholesterol Medications3 | 9 (50%) | 6 (40%) | 3 (100%) | 0.21 |
Abbreviations: BMI, body mass index; TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein
Values are means ± SE.
p-value is based on one-way ANOVA followed by the protected least significant-differences technique for continuous variables and Fisher's Exact test for categorical variables.
information is only available for n=18
information is only available for n=19
information is only available for n=18